Compare Illinois Tool Works Inc. (ITW) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illinois Tool Works Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Illinois Tool Works Inc. trades at $271.88 (market cap $78.17B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Illinois Tool Works Inc. pays a 2.37% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Illinois Tool Works Inc. nearer its low. Which is the better fit depends on your goals.
| ITW | XBI | |
|---|---|---|
Market Cap | $78.17B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $299.60 | $164.28 |
52-Week Low | $241.07 | $85.16 |
Enterprise Value | $86.49B | — |
Dividend Yield | 2.37% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
